We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
John Falcone

John Falcone MD

Second-Year Fellow, Division of Endocrinology, Diabetes & Metabolism, Weill Cornell Medicine/Memorial Sloan Kettering Cancer Center, New York

John N. Falcone, MD, is board-certified in Internal Medicine and a second-year fellow in Endocrinology, Diabetes, and Metabolism at NewYork-Presbyterian Hospital/Weill Cornell and Memorial Sloan-Kettering Cancer Center. John earned his medical degree at Drexel University College of Medicine and completed residency in Internal Medicine at NewYork-Presbyterian Hospital/Weill Cornell. John’s interests are in the relationships of diabetes, insulin resistance, and metabolic diseases to cardiovascular disease and cancer. He is currently pursuing mentored research on the use of whole genome sequencing for precision medicine in patients with diabetes and other metabolic diseases.

Disclosures

Dr. Falcone has no relevant disclosures.

Recent Contributions to PracticeUpdate:

  1. Safety of Metformin in Patients With Diabetes and CKD